Pink Color Research Chemicals BK MDMA Pure BK EBDP Crystal CAS 186028 79 5

 
1. Quick Details
 

Proname: bkedpb, bkmdea BK md ma
CAS : 186028-79-5
Formula : C11H13NO3
Molecular weight: 249.310
Purity: > 99.7%
Appearance: Crystals
Application: Intermediate for organic syntheses
Package: Aluminum foil bag
Transportation: PostNL,EMS, Fedex, DHL
Storage: Dry and cool
Delivery time: Within 24 hours
Port : HK
MOQ: 10gram
Payment: WU,MG,BTC,T/T
 

2. Chemistry

Methylone (also known as "3,4-methylenedioxy-N-methylcathinone", "MDMC", "βk-MDMA" and by the slang term "M1") is an empathogen and stimulant psychoactive drug. It is a member of the substituted amphetamine, substituted cathinone and substituted methylenedioxyphenethylamine classes.
 
Methylone is the substituted cathinone analog of MDMA and the 3,4-methylenedioxy analog of methcathinone. The only structural difference of methylone with respect to MDMA is the substitution of 2 hydrogen atoms by 1 oxygen atom in the β position of the phenethylamine core, forming a ketone group.
 
Methylone was first synthesized by the chemists Peyton Jacob III and Alexander Shulgin in 1996 for potential use as an antidepressant.
 
Starting around 2004, methylone has been sold for recreational use, taking advantage of the absence of legal prohibition of this compound in many countries.

Ethylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine.These are the neurotransmitters in charge of pleasure, reward, motivation and focus.
This is done by inhibiting the reuptake and reabsorption of the neurotransmitters after they have performed their function of transmitting a neural impulse, essentially allowing them to accumulate and be reused, causing physically stimulating and euphoric effects.

In comparison to methylone, it has approximately over 3x lower affinity for the serotonin transporter (which itself has 3x lower affinity than MDMA), while its affinity for the norepinephrine and dopamine transporters is similar.
The results of these differences in pharmacology relative to methylone is that ethylone is less potent in terms of dose, has more balanced catecholaminergic effects relative to serotonergic, and behaves more like a reuptake inhibitor like methylphenidate than a releaser like amphetamine; however, ethylone still has relatively robust releasing capabilities.

4. Pictures